Center for Biotechnology and Innovative Drug Development

History

2022: Opening of the centre

At the end of June 2022, a center for the development of biotechnological and innovative drugs was launched in Moscow. It was launched on the basis of the Moscow Endocrine Plant (MEZ) in the Lefortovsky branch.

The center for the development of biotechnological and innovative medicines took 700 square meters. m. It houses six laboratories. At the initial stage, they will work out and improve technologies for the production of more than 60 active pharmaceutical substances and high-tech drugs obtained by genetic engineering methods (for the treatment of the reproductive system), by peptide synthesis (for the therapy of diseases of the endocrine system and metabolic syndrome) and by methods of chemical synthesis of a new generation of selective inhibitors of blood coagulation factors, hypoglycemic agents, antipsychotics, anxiolytics, muscle relaxants and non-inflammatory agents for anesthesia.

Center for Biotechnical and Innovative Drugs

This is one example of our mutually beneficial cooperation with large manufacturers. In 2016, we assigned the plant the status of an industrial complex, which gives tax benefits. Additional funds are used to expand production and scientific developments, "Moscow Mayor Sergei Sobyanin wrote on his Telegram channel, commenting on the start of the center for the development of biotechnological and innovative medicines.

According to the mayor of the capital, an offset contract was concluded with MEZ. Within two years, the investor must establish in Moscow the production of 20 drugs for the treatment of eye and infectious diseases, depression and painkillers. At the same time, Moscow agreed to purchase medicines from the enterprise for 8 years.

Sobyanin added that on the basis of the Lefortovo branch, the enterprise will create an industrial cluster with a research and laboratory complex. Also, high-tech jobs will be created at the enterprise.^[1]

Notes